Richard Scott Struthers, President & CEO at Crinetics Pharmaceuticals, Inc. (CRNX), sold 214,896 shares at $49.40 ($10.6M) on 2024-05-08, disclosed to the SEC on 2024-05-10.
Scheduled sale ($10.6M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.40 | 107,448 | $5.3M | 50.0% |
| 2 | $49.40 | 107,448 | $5.3M | 50.0% |
| Total | $49.40 avg | 214,896 | $10.6M | 100% |
| Filing → |
| CRNX | SELL | 2025-03-21 | $1.2M | — | Filing → |
| CRNX | SELL | 2024-12-04 | $576K | — | Filing → |
| CRNX | SELL | 2024-04-08 | $4.0M | — | Filing → |